Evidence map›Paper›PMID 32583023›Full record

SynthesisKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2021

Intra-articular injections of platelet-rich plasma in symptomatic knee osteoarthritis: a consensus statement from French-speaking experts.

Florent Eymard, Paul Ornetti, Jérémy Maillet, Éric Noel, Philippe Adam, Virginie Legré-Boyer, Thierry Boyer, Fadoua Allali, Vincent Gremeaux, Jean-François Kaux and 6 more

Erratum issued Registry-linked trialOpen access · hybridAbstract readMeta-AnalysisConsensus Statement
In one paragraph

Synthesis in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07016672 (Efficacy of Therapy With Intra-articular Injections of PRP Compared With Therapy With Intra-articular Injections of HA, in Patients With Grade III or IV GONArthrosis), which is not on this map. Cited by 39 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 4 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07016672 narecruitingnot on this mapstarted 2025, after this paper: background citation

Efficacy of Therapy With Intra-articular Injections of PRP Compared With Therapy With Intra-articular Injections of HA, in Patients With Grade III or IV GONArthrosis: a Prospective Randomized Open-label Study

TypeinterventionalSponsorCentre Hospitalier Intercommunal de Toulon La Seyne sur MerRan2025 to 2028Enrolled150ConditionsKnee OsteoarthritisArmsintra-articular injection of HA, intra-articular injection of PRP
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 4 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 14 institutions in 6 countries.

Florent EymardDepartment of Rheumatology, AP-HP Henri Mondor Hospital, 94010, Créteil Cedex, France.
Paul OrnettiDepartment of Rheumatology, Plateforme d'Investigations Technologiques Dijon University Hospital, INSERM 1093 CAPS, Dijon, France.
Jérémy MailletDepartment of Rheumatology, AP-HP Lariboisière Hospital, 75010, Paris, France.
Éric NoelSanty Orthopedic Center, 69008, Lyon, France.
Philippe AdamImaging Department, Medipole Garonne Sport Clinic, 31100, Toulouse, France.
Virginie Legré-BoyerAmerican Hospital Paris, 92200, Neuilly-sur-Seine, France.
Thierry BoyerIAL Nollet, 75017, Paris, France.
Fadoua AllaliDepartment of Rheumatology, El Ayachi Hospital, Salé, Morocco.
Vincent GremeauxSport Medicine Unit, Division of Physical Medicine and Rehabilitation, Swiss Olympic Medical Center, Lausanne University Hospital, Lausanne, Switzerland.
Jean-François KauxPhysical, Rehabilitation Medicine and Sports Traumatology, SportS2, FIFA Medical Centre of Excellence, IOC Research for Prevention of Injury and Protection of Athlete Health, FIMS Clinical Centre of Sports Medicine, University and University Hospital of Liège, 4000, Liège, Belgium.
Karine LouatiDepartment of Rheumatology, AP-HP Saint-Antoine Hospital, 75012, Paris, France.
Martin LamontagneMontreal University Hospital Center, Montreal, Canada.
Fabrice MichelPhysical Medicine and Rehabilitation Department, CHRU hôpital Jean-Minjoz, 25000, Besançon, France.
Pascal RichetteDepartment of Rheumatology, AP-HP Lariboisière Hospital, 75010, Paris, France.
Hervé BardCabinet médical Vaudoyer, 75007, Paris, France. hervebard@mac.com.
GRIP (Groupe de Recherche sur les Injections de PRP, PRP Injection Research Group)
Assistance Publique – Hôpitaux de Paris · FRAtmel (France) · FRCentre Hospitalier Universitaire de Besançon · FRCentre Orthopédique Santy · FRHôpital américain de paris · FRHôpital El Ayachi · MAHôpital Saint-Michel · FRInserm · FRMédipole Garonne · FROlympic Medical Center · USSorbonne Université · FRUniversité de Montréal · CAUniversité Paris-Est Créteil · FRUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThere has been much debate regarding the use of intra-articular injections of platelet-rich plasma (PRP) as symptomatic treatment for knee osteoarthritis. The objective of this consensus was to develop guidelines for PRP injections in knee osteoarthritis according to the French National Authority for Health recommendations.

methodsFifteen physicians from different French-speaking countries (10 rheumatologists, 4 specialists in rehabilitation and sports medicine and 1 radiologist) were selected for their expertise in the areas of PRP and osteoarthritis. A comprehensive literature review was conducted on Medline including all published therapeutic trials, open studies, meta-analysis and systematic reviews focusing on the effects of PRP in knee OA, as well as fundamental studies concerning the characteristics of the various types of PRP and their mechanisms, indexed before April 2019. Using the method recommended by the French National Authority for Health inspired by the Delphi consensus process, 25 recommendations were finally retained and evaluated. The recommendations were classified as appropriate or not appropriate, with strong or relative agreement, or uncertain if a consensus was not achieved.

resultsAmong the 25 recommendations selected, the main ones are the following: (1) Intra-articular injections of PRP are an effective symptomatic treatment for early to moderate knee osteoarthritis. This recommendation was considered appropriate with a relative agreement (Median = 8; rank = 6-9). Level of evidence 1A. (2) A PRP treatment sequence in knee osteoarthritis may include 1-3 injections. This recommendation was considered appropriate with a strong agreement (Median = 9; rank = 7-9). Level of evidence 1A. (3) Leucocytes-poor PRP should be preferred in knee osteoarthritis. This recommendation was considered appropriate with a relative agreement (Median = 8; rank = 5-9). Level of evidence 5. (4) Intra-articular PRP knee injections should be performed under ultrasound or fluoroscopic guidance. This recommendation was considered uncertain with no consensus (Median = 8; rank = 3-9). Level of evidence 5. (5) PRP should not be mixed with an anesthetic or intra-articular corticosteroid. This recommendation was considered appropriate with a relative agreement (Median = 9; rank = 6-9). Level of evidence 5

conclusionThose 25 recommendations should standardize and facilitate the use of IA PRP injections, which are considered by experts as an effective treatment especially in early or moderate knee OA. Although a strong or relative agreement from the experts was obtained for most of the recommendations, many of them had a very low level of evidence (Level 5) and were principally based on the clinical experience of the experts.

Indexed as

Osteoarthritis, KneePlatelet-Rich PlasmaConsensusHumansHyaluronic AcidInjections, Intra-ArticularKnee JointTreatment OutcomeHyaluronic AcidClinical practiceConsensusIntra-articular injectionsKnee osteoarthritisPlatelet-rich plasma

Identifiers

PMID32583023
PMCPMC8458198
OpenAlexW3037245682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.